Clinical Trials Study
Copyright ©The Author(s) 2025.
World J Exp Med. Sep 20, 2025; 15(3): 103154
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.103154
Table 1 Baseline comparison
Project
Healthy subjects
Hypertension (YDYHS)
Normal reference
t/Z
P value
WBC (× 109/L)5.4860 ± 1.042196.7019 ± 1.523234.00-10.003.2540.002a
RBC (× 1012/L)4.7685 ± 0.415094.8728 ± 0.508174.00-5.500.8090.422
Hb (g/L)141.85 ± 14.147145.79 ± 13.779120-1601.0620.292
PLT (× 109/L)236.45 ± 51.953235.53 ± 47.571100-300-0.0700.944
ALT (U/L)14 (12, 17)22 (15, 27)< 42-3.6770.000a
AST (U/L)17 (15, 19)18 (16, 24)< 38-2.3150.021a
TBil (μmol/L)11.41 (8.84, 16.28)11.10 (9.19, 15.28)5.10-28.00-0.3190.750
ALP (U/L)77.45 ± 18.34983.12 ± 22.37445-1251.0050.319
GGT (U/L)14 (12, 19)22 (16, 30)11-50-3.2320.001a
CR (μmol/L)72.4 (59.9, 84.4)67.1 (59.8, 76.6)44.0-110.0-0.9170.359
BUN (mmol/L)4.12 (3.51, 4.87)4.96 (4.13, 5.90)2.86-8.20-2.8990.004a
Glu (mmol/L)4.54 (4.31, 4.86)5.54 (5.21, 5.95)3.89-6.11-5.4740.000a